FAP and renal cell carcinoma: Panel A illustrates the results for RCC (IMmotion151 study), where patients were stratified based on their FAP expression levels and analyzed across three prognostic TME pathways: T effector, angiogenesis, and myeloid inflammation related gene signatures.